Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects of immune checkpoint inhibitors compared to chemotherapy as first- and second-line treatment of advanced or metastatic urothelial carcinoma.
Bibliographical noteFunding Information:
We thank?the Cochrane Urology Editorial Group, the Methodological?Group and the Cancer Network for their support of this review. We thank G?nter Niegisch, Gunhild von Amsberg, Georgios?Gakis and Andrea Kokorovic?for reviewing the protocol.
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Copyright 2021 Elsevier B.V., All rights reserved.